A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
Public ClinicalTrials.gov record NCT06533553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Phase II Study to Assess the Pharmacodynamic (PD) Effects of Dexpramipexole in Participants With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label Phase II study assessing the PD of dexpramipexole 150 mg twice daily (BID) in participants with eosinophilic COPD. This study will help characterize the profile and duration of reductions of blood absolute eosinophil counts (AEC).
Study identification
- NCT ID
- NCT06533553
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 9, 2024 (Actual)
- Primary completion
- Oct 2025 (Estimated)
- Completion
- Dec 2025 (Estimated)
- Last update posted
- May 14, 2025
2024 – 2025
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site US-10001-017 | Conway | Arkansas | 72032 | — |
| Research Site US-10001-008 | Newport Beach | California | 92663 | — |
| Research Site US-10001-022 | Northridge | California | 91324 | — |
| Research Site US-10001-016 | Westminster | California | 92683 | — |
| Research Site US-10001-030 | Orlando | Florida | 32803 | — |
| Research Site 10001-032 | Champaign | Illinois | 61820 | — |
| Research Site US-10001-021 | Hammond | Indiana | 46324 | — |
| Research Site US-10001-033 | Des Moines | Iowa | 50266 | — |
| Research Site US-10001-020 | Baltimore | Maryland | 21224 | — |
| Research Site US-10001-024 | Farmington Hills | Michigan | 48336 | — |
| Research Site US-10001-005 | Saint Charles | Missouri | 63301 | — |
| Research Site US-10001-001 | St Louis | Missouri | 63110 | — |
| Research US-10001-010 | Charlotte | North Carolina | 28277 | — |
| Research Site US-10001-025 | Charlotte | North Carolina | 28293 | — |
| Research Site US-10001-007 | Gastonia | North Carolina | 28054 | — |
| Research Site US-10001-004 | Columbus | Ohio | 43215 | — |
| Research Site US-10001-002 | DuBois | Pennsylvania | 15801 | — |
| Research Site US-10001-013 | Philadelphia | Pennsylvania | 19140 | — |
| Research Site US-10001-023 | East Providence | Rhode Island | 02914 | — |
| Research Site US-10001-012 | Rock Hill | South Carolina | 29732 | — |
| Research Site US-10001-009 | Corsicana | Texas | 75110 | — |
| Research Site US-10001-038 | Houston | Texas | 77030 | — |
| Research Site 10001-026 | McKinney | Texas | 75069 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06533553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06533553 live on ClinicalTrials.gov.